23-25 January,2020 Athens
![]() |
![]() |
![]() |
![]() |
P02-01 | Efficacy and safety of elbasvir/grazoprevir treatment in treatment-experienced and co-morbid HCV GT1b patients | Pavel Bogomolov | ![]() |
![]() |
|||
P01-01 | Filling the gaps: HCV treatment at a needle exchange program in Sweden (project Actionne) | Marianne Alanko | ![]() |
![]() |
|||
P06-01 | Metabolic programming of exhausted CD8 T cells in chronic viral hepatitis | Frances Winkler | ![]() |
![]() |
|||
P04-01 | The role of sphingolipids as potential biomarkers of failure to direct acting antiviral therapy in chronic HCV infection | Aissa Rhrig | ![]() |
![]() |
|||
P05-01 | Targeting hepatitis B virus with CRISPR/Cas9 | Maria Guadalupe Martinez | ![]() |
![]() |
|||
P03-01 | Therapy of hepatitis C in people who inject drugs: focus on adherence | Sona Frankova | ![]() |
![]() |
|||
P04-02 | Hepatitis C virus dysregulates polyamine and proline metabolism and perturbs urea cycle | Alexander Ivanov | ![]() |
![]() |
|||
P05-02 | Reaching people who inject drugs most in need for HCV testing, diagnosis and linkage to care through a community-based program in Athens, Greece (ARISTOTLE HCV-HIV) | Sotiris Roussos | ![]() |
![]() |
|||
P02-02 | hepatitis e virus infection among people living with hiv / aids virus in kano state | Lawal Dahiru | ![]() |
![]() |
|||
P06-02 | A transient early HBV DNA increase during PEG-IFNa therapy of hepatitis D is associated with subsequent HDV RNA response and HBsAg loss | Olympia Anastasiou | ![]() |
![]() |
|||
P03-02 | Development of Bipolymer based novel Nanoparticles in Microsphere system as vaccine adjuvant | Prakash Gosain | ![]() |
![]() |
|||
P01-02 | Development and Characterization of Oral combination vaccine against Hepatitis B and Influenza | Mani Bhargava | ![]() |
![]() |
|||
P04-03 | HCV course, efficacy and safety of DAA treatment in patients with inherited blood disorders | Abdourahman Jallow | ![]() |
![]() |
|||
P05-03 | Homocysteine mediated oxidative stress is detrimental for pregnancy complications and outcome in Hepatitis E virus infected cases: A northeast Indian patients based study | Diptika Tiwari | ![]() |
![]() |
|||
P03-03 | Lipid based Nanoparticulate system for effective vaccine delivery | Priyanka Gosain | ![]() |
![]() |
|||
P01-03 | Antibody coated Liposomes for Transmucosal Vaccination | Saurabh Bhargava | ![]() |
![]() |
|||
P02-03 | HCV treatment with DAA in children and adolescents in Russian Federation (single center study) | Elena Egorova | ![]() |
![]() |
|||
P06-03 | A CRISPR/Cas9 screen to identify host factors required for the hepatitis E virus life cycle | Noémie Oechslin | ![]() |
![]() |
|||
P01-04 | Prevalence of hepatitis C virus infection among men who have sex with men in Moscow | Pavel Bogomolov | ![]() |
![]() |
|||
P05-04 | Potential usefulness of chicken egg yolk immunoglobulins for immunotherapy of hepatitis b | Livia Villar | ![]() |
![]() |
|||
P06-04 | Hepatitis b virus x protein is required for viral gene expression, indirectly controls cccdna amplification and is dispensable for dna synthesis | Amir Shlomai | ![]() |
![]() |
|||
P04-04 | After the achivement of sustained virological response by direct acting antivirals, does the age influence the recovery of the hepatic reserve? | Yoshiyasu Karino | ![]() |
![]() |
|||
P03-04 | An undetected Hepatitis C outbreak preceded the 2011 HIV outbreak among persons who inject drugs in Athens, Greece: Insights from a mathematical modelling study | Ilias Gountas | ![]() |
![]() |
|||
P02-04 | hepatitis b infection: is it a real public health threat in upper Egypt? | Mahmoud S. Elzalabany | ![]() |
![]() |
|||
P03-05 | The impact of treatment emerging resistance associated substitution on outcomes of re-treatment using new generation HCV treatments: Nation-wide real world analysis | Yael Gozlan | ![]() |
![]() |
|||
P02-05 | Clinicopathologic Characteristics of Follicular Lymphoma in Hepatitis C Virus-Infected Patients | Harrys Torres | ![]() |
![]() |
|||
P01-05 | health-related quality of life evaluation using questionnaires in patients with chronic hepatitis c virus infection before receiving direct-acting antivirals treatment | Raluca Dirtu | ![]() |
![]() |
|||
P05-05 | Molecular analysis of HCV subtype 1a dispersal patterns among inmates in Greece: HCV transmissions are not related to incarceration | Evangelia-Georgia Kostaki | ![]() |
![]() |
|||
P06-05 | Type I interferon exposure augments follicular T helper cell phenotype and functionality | Katharina Zoldan | ![]() |
![]() |
|||
P06-06 | Prospective study of HBV cccDNA kinetics in a French multicenter cohort of liver transplant patients (ECOGREFFE) reveals very early graft infection despite NUCHBIG prophylaxis | Franois Villeret | ![]() |
![]() |
23-25 January,2020 Athens
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|